SpeechPathology.com Phone: 800-242-5183


eLuma Online Therapy - Love What You Do - May 2023

Size of TEP When Placing at Time of Primary Puncture

Julie Bishop-Leone, M.A., CCC-SLP

October 14, 2013

Share:

Question

What size tracheoesophageal prosthesis (TEP) is typically placed at the time of the primary puncture?

Answer

The party wall is 7.4 mm thick in cadaver models.  In Europe, they typically place an 8 mm TEP at the time of the puncture.  In Europe, I think you see fewer patients that have chemoradiation and less complicated patients for some reason.  In the US, I always recommend that most patients have a 10 mm TEP.  A 10 gives you a little extra "wiggle room" and typically a 10 is perfect.  If there is a flap, you might consider a 12 1/2 mm or a 15 mm.  I have not had any incidences of a 10 not working in a non-flapped patient.

Julie Bishop-Leone’s career as a Speech Language Pathologist spans 20 years first at the University of Michigan, Ann Arbor then as Clinical Manager of Speech Pathology and Audiology at the University of Texas, M.D. Anderson Cancer Center in Houston, TX.  Specializing in alaryngeal voice restoration and swallowing she has participated in numerous clinical trials and co-authored several peer-reviewed papers focused on the head and neck oncology patient.


julie bishop leone

Julie Bishop-Leone, M.A., CCC-SLP

Julie Bishop-Leone’s career as a Speech Language Pathologist spans 20 years first at the University of Michigan, Ann Arbor then as Clinical Manager of Speech Pathology and Audiology at the University of Texas, M.D. Anderson Cancer Center in Houston, TX.  Specializing in alaryngeal voice restoration and swallowing she has participated in numerous clinical trials and co-authored several peer-reviewed papers focused on the head and neck oncology patient. In addition to her extensive clinical experience with tracheoesophageal voice restoration, she has directed and been an invited faculty member at national seminars and training programs in the area of laryngectomy rehabilitation.  Ms. Bishop-Leone has been employed by Atos Medical Inc for the last five years and is a founding member of the Educational Division of Atos Medical Inc. 


Related Courses

Understanding Skin Physiology and Management After Total Laryngectomy
Presented by Julie Bishop-Leone, MA, CCC-SLP
Video

Presenter

Julie Bishop-Leone, MA, CCC-SLP
Course: #9002Level: Intermediate1 Hour
  'informative'   Read Reviews
This course will describe the function of skin, as well as types of and reasons for skin breakdown after total laryngectomy surgery. Participants will learn about practical solutions for preventing and treating irritation from peristomal baseplates, in order to facilitate patients’ ability to wear a Heat Moisture Exchanger for pulmonary rehabilitation. This course is presented jointly with Atos Medical.

Tracheoesophageal Voice: Basic Troubleshooting and Practical Solutions
Presented by Julie Bishop-Leone, MA, CCC-SLP
Video

Presenter

Julie Bishop-Leone, MA, CCC-SLP
Course: #9678Level: Intermediate1 Hour
  'Julie has always been a great resource for TEP information and management'   Read Reviews
This course provides information to help participants differentiate between central and peripheral leakage of tracheoesophageal voice prostheses and identify the potential causes. Specific solutions are discussed, including problem-solving applicable to both inpatient and outpatient settings.

Behavioral Frameworks for Dementia Management
Presented by Mary Beth Mason, PhD, CCC-SLP, Robert W. Serianni, MS, CCC-SLP, FNAP
Video

Presenters

Mary Beth Mason, PhD, CCC-SLPRobert W. Serianni, MS, CCC-SLP, FNAP
Course: #9473Level: Intermediate1 Hour
  'It was new information that I wasn't familiar with'   Read Reviews
This course will focus on cognitive-communication intervention strategies for various dementia presentations and will provide a review of evidence-based treatment. Behavioral frameworks along with their rationales will be introduced and applied across several dementia types and mild, moderate and severe levels of impairment.

Dysphagia in Neurodegenerative Disease
Presented by Debra M. Suiter, PhD, CCC-SLP, BCS-S
Video

Presenter

Debra M. Suiter, PhD, CCC-SLP, BCS-S
Course: #9732Level: Intermediate1 Hour
  'I appreciated the time the presenter took to review the information and provided examples during specific treatment recommendations'   Read Reviews
Dysphagia is common in individuals with amyotrophic lateral sclerosis (ALS) and Parkinson’s disease. This course discusses the underlying pathophysiology and appropriate treatment programs for each disease, as well as use of alternate methods of nutrition/hydration.

20Q: Induced Laryngeal Obstruction - An Overview for Speech-Language Pathologists
Presented by Robert Brinton Fujiki, PhD, CCC-SLP
Text

Presenter

Robert Brinton Fujiki, PhD, CCC-SLP
Course: #10761Level: Intermediate1 Hour
  'Material was very well organized and presented'   Read Reviews
The nature of induced laryngeal obstruction, including comorbidities and causes, and the speech-language pathologist’s role in evaluation and treatment of this disorder are described in this course. Current diagnostic and treatment practices and research updates pertaining to the condition are discussed.

Our site uses cookies to improve your experience. By using our site, you agree to our Privacy Policy.